Sponsors (35)
The bill improves early detection, standardization, and prevention emphasis for dementia—benefiting Medicare patients, caregivers, and public health—but increases fiscal pressure, potential out‑of‑pocket burdens, administrative work for clinicians, and raises equity and privacy risks unless funding, reimbursement, and equity safeguards are enacted.
Medicare beneficiaries will receive routine, standardized cognitive screening (with documented results) at AWVs and IPPEs starting Jan 1, 2026, improving early detection of dementia and enabling better care coordination and referrals.
Older adults and the general public may benefit from stronger public‑health emphasis on dementia risk reduction (e.g., hypertension control, smoking cessation, physical activity), which could prevent a substantial share of cases over time.
Seniors covered by Medicare and Medicaid could receive greater attention and resources for Alzheimer’s care planning and support as the bill highlights large patient numbers and costs.
Taxpayers and federal budgets face growing pressure from projected Medicare/Medicaid Alzheimer’s costs (estimated to approach $1.1 trillion by 2050), increasing long‑term fiscal exposure.
Patients and families could continue to face or experience higher out‑of‑pocket costs for Alzheimer’s care (about $91 billion currently), imposing substantial financial strain without additional coverage changes.
Racial and gender disparities highlighted by the bill (higher prevalence among Black, Latino, and women) risk perpetuating unequal outcomes if mitigation and equitable access measures are not implemented.
Based on analysis of 2 sections of legislative text.
Requires use of NIA‑identified cognitive screening tools and documentation of the tool and results during Medicare AWVs and IPPEs starting Jan 1, 2026.
Official title: To amend title XVIII of the Social Security Act to provide for certain cognitive impairment detection in the Medicare annual wellness visit and initial preventive physical examination.
Introduced May 19, 2025 by Linda T. Sánchez · Last progress May 19, 2025
Requires that Medicare Annual Wellness Visits (AWVs) and Initial Preventive Physical Examinations (IPPEs) include use of a National Institute on Aging (NIA)–recommended cognitive impairment detection tool and that the chosen tool and assessment results be documented in the patient’s medical record. The requirement applies to services furnished on or after January 1, 2026. Adds detection of cognitive impairment to the list of required elements for the Medicare IPPE and replaces the AWV cognitive assessment provision with a mandate to use an NIA-identified primary-care selection tool and record the tool and results in medical records.